NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (cg-RX-API-DMAC7.html)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (cg-RX-API-DMAC7.html) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (cg-RX-API-DMAC7.html)
FR (1) FR3150M (cg-RX-API-DMAC7.html)
GB (1) GB1080599A (cg-RX-API-DMAC7.html)
LU (1) LU45106A1 (cg-RX-API-DMAC7.html)
NL (1) NL302572A (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
MX2007006171A (es) 2004-11-26 2007-10-08 Ucl Business Plc Composiciones que comprenden ornitina y acetato.
EP3263100B1 (en) 2009-04-03 2020-04-01 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
KR101715008B1 (ko) 2009-06-08 2017-03-22 유씨엘 비즈니스 피엘씨 L―오르니틴 페닐아세테이트를 사용한 문맥압 항진증의 치료 및 간 기능 회복
EP2625162B1 (en) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
CA2968544A1 (en) 2014-11-24 2016-06-02 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
EP3337473A4 (en) 2015-08-18 2019-04-17 Ocera Therapeutics, Inc. TREATMENT AND PREVENTION OF MUSCLE WOUND BY L-ORNITHIN IN COMBINATION WITH AT LEAST ONE PHENYL ACETATE AND PHENYL BUTYRATE
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
GB1080599A (en) 1967-08-23
FR3150M (fr) 1965-02-22
LU45106A1 (cg-RX-API-DMAC7.html) 1964-02-24
BE641880A (cg-RX-API-DMAC7.html) 1964-04-16

Similar Documents

Publication Publication Date Title
BE616548R (cg-RX-API-DMAC7.html)
BE627343A (cg-RX-API-DMAC7.html)
BE614403A (cg-RX-API-DMAC7.html)
BE627733A (cg-RX-API-DMAC7.html)
BE489310A (cg-RX-API-DMAC7.html)
BE538252A (cg-RX-API-DMAC7.html)
BE538831A (cg-RX-API-DMAC7.html)
BE541929A (cg-RX-API-DMAC7.html)
BE553896A (cg-RX-API-DMAC7.html)
BE559145A (cg-RX-API-DMAC7.html)
BE586180A (cg-RX-API-DMAC7.html)
BE592434A (cg-RX-API-DMAC7.html)
BE599783A (cg-RX-API-DMAC7.html)
BE604335A (cg-RX-API-DMAC7.html)
BE608197A (cg-RX-API-DMAC7.html)
BE609543A (cg-RX-API-DMAC7.html)
BE612190A (cg-RX-API-DMAC7.html)
BE612311A (cg-RX-API-DMAC7.html)
BE612464A (cg-RX-API-DMAC7.html)
BE612847A (cg-RX-API-DMAC7.html)
BE612926A (cg-RX-API-DMAC7.html)
BE613108A (cg-RX-API-DMAC7.html)
BE613190A (cg-RX-API-DMAC7.html)
BE613298A (cg-RX-API-DMAC7.html)
BE613319A (cg-RX-API-DMAC7.html)